BCL2 and diffuse large B-cell lymphoma: To address the translational impact of our study, we performed a large meta-analysis on the transcriptomic data of DLBCL patients to identify targets in relation to the BECN1 and BCL2 genes that together determine the cell fate in response to chemotherapy through governing pathways such as autophagy, cell survival, and cell death.